SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2 | -100.0% | 3,200 | -17.9% | 0.00% | – |
Q3 2022 | $6,000 | – | 3,898 | +34.4% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 2,900 | -63.8% | 0.00% | – |
Q1 2022 | $1,000 | -92.9% | 8,000 | +536.9% | 0.00% | -100.0% |
Q4 2018 | $14,000 | -33.3% | 1,256 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $21,000 | +23.5% | 1,256 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $17,000 | -26.1% | 1,256 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $23,000 | -62.9% | 1,256 | -90.1% | 0.00% | -33.3% |
Q4 2017 | $62,000 | -47.9% | 12,700 | -47.7% | 0.00% | -25.0% |
Q3 2017 | $119,000 | +52.6% | 24,300 | -19.0% | 0.00% | +33.3% |
Q2 2017 | $78,000 | +457.1% | 30,000 | -21.1% | 0.00% | – |
Q1 2017 | $14,000 | -82.9% | 38,000 | -35.6% | 0.00% | -100.0% |
Q4 2016 | $82,000 | +2.5% | 58,993 | -64.1% | 0.00% | 0.0% |
Q3 2016 | $80,000 | -73.8% | 164,193 | +32.5% | 0.00% | -80.0% |
Q2 2016 | $305,000 | +43.2% | 123,923 | -38.6% | 0.02% | +7.1% |
Q1 2016 | $213,000 | -68.5% | 201,816 | +11.6% | 0.01% | -63.2% |
Q4 2015 | $677,000 | – | 180,916 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |